Regulatory strategies, submissions, and compliance
Moderna, Inc. announced in an 8-K filing that the FDA issued a Refusal-to-File (RTF) letter for its Biologics License Application (BLA) for mRNA-1010, its investigational seasonal influenza vaccine.
Piper Sandler Companies (PIPR) announced the appointment of Stuart M. Essig to its Board of Directors, effective February 4, 2026.
Regeneron Pharmaceuticals announced its fourth quarter and full year 2025 financial results, showcasing revenue growth driven by Dupixent and EYLEA HD. Q4 revenues increased 3% to $3.
AbbVie reported its full-year and fourth-quarter 2025 financial results, showcasing strong growth driven by its immunology portfolio, particularly Skyrizi and Rinvoq.